Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza virus strain H5N1 clade 1 vaccine - Sanofi

Next Previous
Drug Profile

Influenza virus strain H5N1 clade 1 vaccine - Sanofi

Alternative Names: Avian influenza (bird flu) virus vaccine - Sanofi/NIAID; Emerflu; H5N1 influenza vaccine - Sanofi; H5N1 split antigen influenza vaccine Alum adjuvanted - Sanofi; Low-dose H5N1 vaccine - Sanofi; Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/Vietnam/1194/2004 (NIBRG-14) - Sanofi; Pandemic influenza vaccine - Sanofi

Latest Information Update: 20 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur
  • Developer Sanofi; Sanofi Pasteur
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Influenza A virus H5N1 subtype

Most Recent Events

  • 20 Sep 2024 Discontinued - Phase-II for Influenza A virus H5N1 subtype (In children, Prevention) in Thailand (IM) prior to September 2024 (Sanofi pipeline, September 2024)
  • 29 Nov 2017 Sanofi Pasteur's influenza virus strain H5N1 clade 1 vaccine is registered in USA and Australia and will not be sold commercially
  • 20 Mar 2015 The vaccine is approved in USA and Australia for Influenza A virus H5n1 subtype (Prevention)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top